Stifel lowered the firm’s price target on WM (WM) to $236 from $252 and keeps a Buy rating on the shares. The firm lowering its target to reflect modestly lowered estimates and an increased risk premium due to more concerns around the Stericycle acquisition, but expects “very healthy” free cash flow in 2026 due largely to a step down of investment spending and increased profits generated from those investments, the analyst tells investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WM: